Clinical Trial Update: 5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes [Phase 1]

View source ↗

Summary

Phase 1 trial assessing 5-Fluoro-2'-Deoxycytidine with tetrahydrouridine in adults with acute myeloid leukemia or myelodysplastic syndromes; the study has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• 5-Fluoro-2'-Deoxycytidine (5-fluoro-2'-deoxycytidine)
• Tetrahydrouridine (tetrahydrouridine)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Adult Acute Myeloid Leukemia, de Novo Myelodysplastic Syndromes | Phase 1 | Status: COMPLETED